GHRL and benign prostatic hyperplasia: Of two studies in prostate cancer, 1 in 30 patients vs 50 controls with benign prostate hyperplasia (BPH) found no association of ghrelin level with presence or progression of cancer (Mungan et al. 2008) (Table 1).